Reaction

Flagellate Dermatitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 64 reports · 4 co-occurring drugs

As of the last recalculation, Flagellate Dermatitis appears in 64 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is BLEOMYCIN SULFATE (PRR 1,668.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Bleomycin Sulfate291,668.61,673.4
Mesna Injection5213.4213.5
Mesna5209.4209.6
Pemetrexed9158.7158.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.